Article

The clinical efficacy of cardiac rehabilitation programs is clearly recognized.
Yet, as regards the three main currently employed strategies (exercise,
education, and psychobehavioral support), new ideas regularly appear, stemming
from studies aimed at providing proof of their efficacy and innocuousness, along
with optimal modes of prescription and, at times, their cost-benefit ratio. This
ongoing work, which was initially developed in view of enriching the "What's new
in?" section of the Sofmer website, represents a selection of articles that may
be non-exhaustive, yet is maximally diversified and as representative as possible
of the main 2011 highlights in the field of cardiovascular prevention. Each of
the articles selected puts forward an original idea, confirms the existence of an
effect that was suspected or has had some impact on clinical practice in the
field of non-pharmacological management of cardiovascular disease. In line with
the multidisciplinary approach of Physical Medicine and Rehabilitation (PMR), the
Sofmer cardiovascular rehabilitation group has associated itself with a wide
range of specialists (PMR, cardiologists, exercise physiologists, experts in the
science and technology of physical activities), all of whom are involved in
clinical research and the management of more and more patients. Our objective was
consequently to compile a selection of commented articles most likely to interest
the different operatives (doctors, nurses, physiotherapists, dietitians, adapted
physical activity instructors, psychologists) working with these patients in
rehabilitation units or in phase III associative structures. Their goals may
vary: (1) learners may wish to further their knowledge of cardiac rehabilitation
techniques; (2) practitioners may be interested in continued education but not
have the time for regular bibliographic updates; (3) researchers may be intent on
informing themselves on the latest breakthroughs and/or arousing their
imagination... Enjoy your reading!
CI - Copyright (c) 2012 Elsevier Masson SAS. All rights reserved.

Langue : ANGLAIS